SRZN
Surrozen
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
SRZN Profile
Surrozen, Inc.
A company that pioneered targeted therapeutics for tissue repair and regeneration
171 Oyster Point Boulevard, Suite 400, South San Francisco, California
--
Surrozen, Inc., a biotech company incorporated in Delaware on August 21, 2020, is dedicated to discovering and developing drug candidates to selectively modulate the Wnt pathway. Surrozen is developing tissue-specific antibodies designed to harness the body's existing bioremediation mechanisms for potential applications in a variety of disease areas, including intestinal, liver, retina, cornea, lung, kidney, cochlea, skin, pancreas and central nervous system diseases.